NH - NantHealth Inc Stock quote - CNNMoney.com Find real-time NH - NantHealth Inc stock quotes, company profile, news and forecasts from CNN Business. Find real-time NH - NantHealth Inc stock quotes, company profile, news and forecasts from (NH) - NantHealth Q4 Earnings Preview | Benzinga Mar 14, 2018 · Stock Performance. Over the past 52-week period, shares of NantHealth have declined 11.46 percent. Given that these returns are generally negative, long-term shareholders are … NH Price Target and Analyst Ratings (NantHealth) | MarketBeat Oct 31, 2019 · 1 Wall Street analysts have issued ratings and price targets for NantHealth in the last 12 months. Their average twelve-month price target is $1.00, suggesting that the stock has a possible downside of 32.89%. The high price target for NH is $1.00 and the low price target for NH is $1.00.
NantHealth, Inc., together with its subsidiaries, operates as a healthcare technology company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care.
Soon-Shiong’s NantHealth reports $184 million loss for 2016. By Rebecca Robbins @rebeccadrobbins. March 30, 2017. Evan Vucci/AP. 18 stock-moving events to watch Recommended Stories. Here's Why NantHealth, Inc. Continued to Disappoint in ... Here's Why NantHealth, Inc. Continued to Disappoint in July Despite a successful IPO in June, the healthcare information company needs more than gargantuan aspirations to keep it aloft. NantHealth Stock Forecast | NH Stock Predictions See NH stock predictions by 1 financial experts and find out if their NantHealth stock forecast (NH) is more bullish in comparison to other stocks in the Technology sector. NantHealth Reports 2018 First-Quarter Financial Results ... May 16, 2018 · Financial results for the 2018 first quarter included approximately $3.3 million loss from related party equity method investment including impairment loss, $2.7 million of stock-based compensation expense, $2.2 million of intangible amortization, and $1.2 million of non-cash interest expense related to convertible notes, totaling $0.09 per share.
In January 2019, NantHealth received a delisting warning from Nasdaq "because the Company’s common stock failed to maintain a minimum closing bid price of $1.00 for 30 consecutive business days." At the time, the market value of the company was approximately $57m.
NantHealth Inc NH - Quotes, Financials, News, Charts and ... NantHealth, Inc. is an evidence-based, personalized healthcare company, which engages in the provision of treatment for critical diseases such as cancer in United States, the United Kingdom Will NANTHEALTH Revolutionize the U.S. Healthcare System ... Jun 23, 2014 · In evaluating the merits of a company, one promising indication of future success is to look at the pedigree of the company's leadership. This is where most over-the-counter stocks fail miserably, and this is also where success can beget further success for tenured executives who have proven their talents for creating value. One man, Patrick Soon-Shiong, has done just this and made … Will a NantHealth IPO Happen in 2015? - Nanalyze Will a NantHealth IPO Happen in 2015? In a June 2014 article, we highlighted a company called NantHealth , led by Patrick Soon-Shiong who is the wealthiest American in the healthcare industry having amassed a fortune of $7.2 billion for building and selling Abraxis Biosciences and …
